Women Deserve Better - Survivors Deserve Better
BreastDefense can detect all major sub-types of breast cancer (for stages 1-4) with a test that balances 98.5% for both sensitivity and specificity. BreastDefense will distinguish benign cells from those containing invasive breast cancer. BreastDefense aims to achieve the same degree of accuracy in monitoring remission.
Once breast cancer treatments are completed, survivors want to monitor remission.
It can be a time of worry for women who fear the cancer could come back.
BreastDefense, an easy and routine blood draw will put these fears at bay.